Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ONVO

Organovo Holdings Inc

Mar 13 • 12:46PM ET

0.4155

Dollar change -0.0155
Percentage change -3.60	%

Healthcare • Biotechnology • USA • NASD

Peers: MDXG FATE VCEL BLUE CYRX CRSP EDIT NTLA ALLO SGMO

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.86	Insider Own	1.67%	Shs Outstand	17.45M	Perf Week	-19.82%
Market Cap	7.25M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	17.16M	Perf Month	19.98%
Income	-12.38M	PEG	-	EPS next Q	-	Inst Own	14.28%	Short Float	8.01%	Perf Quarter	-6.84%
Sales	0.12M	P/S	60.41	EPS this Y	-	Inst Trans	-11.25%	Short Ratio	0.17	Perf Half Y	-20.10%
Book/sh	0.02	P/B	19.55	EPS next Y	-	ROA	-194.66%	Short Interest	1.38M	Perf Year	-58.87%
Cash/sh	0.07	P/C	6.25	EPS next 5Y	-	ROE	-378.40%	52W Range	0.32 - 1.83	Perf YTD	-9.65%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.06%	ROI	-1365.49%	52W High	-77.30%	Beta	0.94
Dividend TTM	-	Quick Ratio	0.72	Sales past 5Y	-54.97%	Gross Margin	-130.33%	52W Low	31.74%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	0.72	EPS Y/Y TTM	60.27%	Oper. Margin	-10293.44%	RSI (14)	46.00	Volatility	13.58% 22.29%
Employees	20	Debt/Eq	3.67	Sales Y/Y TTM	-49.59%	Profit Margin	-10151.64%	Recom	3.00	Target Price	5.40
Option/Short	Yes / Yes	LT Debt/Eq	1.50	EPS Q/Q	51.72%	Payout	-	Rel Volume	0.06	Prev Close	0.43
Sales Surprise	-26.83%	EPS Surprise	46.15%	Sales Q/Q	380.00%	Earnings	Nov 07	Avg Volume	7.89M	Price	0.42
SMA20	-21.30%	SMA50	-5.10%	SMA200	-22.35%	Trades		Volume	238,027	Change	-3.60%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-18	Initiated	H.C. Wainwright	Buy	$2.50
Nov-10-17	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-25-17	Initiated	Raymond James	Outperform
Aug-11-15	Downgrade	Cantor Fitzgerald	Buy → Hold
Jun-29-15	Initiated	Piper Jaffray	Overweight	$5
Jun-29-15	Initiated	Jefferies	Buy	$5

Mar-11-25 07:00AM	Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors (GlobeNewswire)
Mar-06-25 08:05AM	Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises (GlobeNewswire)
Feb-25-25 08:05AM	Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company (GlobeNewswire) +244.17%
Feb-19-25 09:17AM	Organovo: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
Jan-06-25 08:05AM	Organovo Announces Appointment of Norman Staskey as Chief Financial Officer (GlobeNewswire) +7.15%
08:05AM	Loading…
Nov-20-24 08:05AM	Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting (GlobeNewswire)
Nov-13-24 08:06AM	Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases (GlobeNewswire)
Nov-08-24 04:15PM	Organovo: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -6.60%
Jul-16-24 08:05AM	Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis (GlobeNewswire) -8.55%
Jun-03-24 11:52AM	ONVO Stock Earnings: Organovo Holdings Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace) +5.78%
May-21-24 08:05AM	Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease (GlobeNewswire)
May-14-24 11:00AM	Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) (GlobeNewswire)
May-09-24 07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
May-08-24 08:00PM	Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering (GlobeNewswire) +5.49%
Apr-15-24 08:13AM	Organovo's fatty liver disease drug meets main goal in mid-stage study (Reuters) +33.65%
08:05AM	Loading…
08:05AM	Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo (GlobeNewswire)
Mar-28-24 08:32PM	Top 15 3D Printing Companies in the US (Insider Monkey)
Feb-08-24 05:52PM	Organovo: Fiscal Q3 Earnings Snapshot (Associated Press Finance) -10.00%
Jan-25-24 08:05AM	Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn's and Colitis Congress (GlobeNewswire)
Jan-09-24 08:05AM	Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn's and Colitis Congress (GlobeNewswire)
Dec-06-23 08:05AM	Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results (GlobeNewswire) -6.04%
Nov-13-23 08:05AM	CORRECTION Organovo Highlights FXR314 Combination Therapy Potential and Plan (GlobeNewswire) +5.93%
Nov-10-23 05:08AM	Organovo: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -7.53%
Nov-08-23 08:05AM	Organovo Highlights FXR314 Combination Therapy Potential and Plan (GlobeNewswire) -5.18%
Oct-10-23 07:18AM	ONVO: A Company With Great Technology to Impact Health Care (Zacks)
Sep-08-23 12:46PM	Organovo to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-25-23 07:36PM	Is Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com) -13.16%
Aug-23-23 08:05AM	Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data (GlobeNewswire) +5.43%
Jul-12-23 03:01AM	Net Asset Value(s) (Business Wire)
May-25-23 10:49AM	Cathie Wood is Selling These 12 Stocks in 2023 (Insider Monkey)
08:05AM	Loading…
Mar-21-23 08:05AM	Organovo Announces FXR Program (GlobeNewswire)
Feb-10-23 05:12AM	Will Organovo Holdings (NASDAQ:ONVO) Spend Its Cash Wisely? (Simply Wall St.) -17.86%
Nov-15-22 08:05AM	Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohns Disease Drug Candidates (GlobeNewswire)
Sep-06-22 08:20AM	Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) +13.42%
08:05AM	Organovo Announces Postponement of Annual Meeting of Stockholders (GlobeNewswire)
Jul-08-22 08:05AM	We're Not Very Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Rate (Simply Wall St.) +29.17%
May-17-22 08:05AM	Organovo Achieves 3D Tissue Model for Crohns Disease (GlobeNewswire) +5.86%
Mar-03-22 10:13PM	Why Organovo Holdings, Inc. Stock Soared 49.7% This Week (Motley Fool) -11.34%
Mar-01-22 08:05AM	UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents (GlobeNewswire) +5.90%
Feb-23-22 08:05AM	Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents (GlobeNewswire) +5.47%
Feb-18-22 04:00PM	Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
01:00PM	Organovo Welcomes New Sr. Vice President of Strategy and Business Development (GlobeNewswire)
Feb-12-22 02:09PM	10 3D Printing Companies to Watch in 2022 (Insider Monkey)
Feb-04-22 10:11AM	Cathie Wood Targets Illiquid Assets and Limits Exits in New Fund (Bloomberg)
Feb-02-22 12:00PM	Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents (GlobeNewswire)
Jan-21-22 11:37AM	15 Worst Stock Picks of Cathie Wood (Insider Monkey)
Jan-10-22 12:00PM	Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk (GlobeNewswire)
Dec-30-21 09:24AM	Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation (Simply Wall St.)
Nov-30-21 08:05AM	Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022 (GlobeNewswire)
Sep-17-21 04:10PM	Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum (GlobeNewswire) -7.57%
Jun-22-21 10:17AM	/C O R R E C T I O N from Source -- RBC Global Asset Management Inc./ (PR Newswire) +5.02%
Jun-15-21 11:38AM	Is Organovo Holdings Inc (ONVO) A Good Stock To Buy? (Insider Monkey)
Mar-02-21 08:05AM	Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE) (GlobeNewswire)
Feb-07-21 09:19AM	15 Biggest 3D Companies in the World (Insider Monkey)
Sep-03-20 04:05PM	Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -5.75% -11.54%
Aug-17-20 08:05AM	Organovo Announces One-for-Twenty Reverse Stock Split (GlobeNewswire) -13.52%
Jun-10-20 03:43PM	Hedge Fund Sentiment Is Stagnant On Organovo Holdings Inc (ONVO) (Insider Monkey) -7.54%
Apr-08-20 10:32AM	Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT (Thomson Reuters StreetEvents) +13.63%
07:53AM	The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO (Benzinga)
Apr-07-20 04:12PM	Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics (Business Wire)
Apr-02-20 08:00AM	Organovo Holdings Founder Calls on Board of Directors to Accept Stockholders Opposition to the Illogical Merger With Tarveda Therapeutics (GlobeNewswire) -13.19%
Mar-31-20 06:30PM	Organovo Holdings, Inc. Reminds Stockholders About Adjourned Special Meeting of Stockholders (Business Wire) +43.36% -28.07%
03:25PM	Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt (GlobeNewswire)
Mar-28-20 02:27PM	How 3D-printing is playing a role in coronavirus testing (Yahoo Finance)
Mar-27-20 04:05PM	Organovo Holdings, Inc. Announces Adjournment of Special Meeting of Stockholders (Business Wire)
Mar-23-20 03:30PM	Organovo Holdings Founder Issues Letter Regarding Alternative Paths to Illogical Merger With Tarveda Therapeutics to Stockholders (GlobeNewswire) -10.80%
Mar-19-20 02:36PM	Organovo Founder Issues Letter to Stockholders Regarding Major Missteps and Misjudgment of the Companys Board of Directors (GlobeNewswire) +20.48%
Feb-26-20 08:30AM	Organovo Files Definitive Proxy Statement and Sends Letter to Stockholders (Business Wire) -9.67%
Jan-21-20 07:00AM	The Case Against Tarveda: An Open Letter to Organovo Shareholders (Business Wire) -11.92%
Jan-07-20 08:00AM	An Open Letter to Organovo Shareholders: Organovo Founder Sees Continued Success in Bioprinting (Business Wire) +8.60%
Dec-17-19 07:03PM	Is Organovo Holdings Inc (ONVO) A Good Stock To Buy? (Insider Monkey) -13.11%
Dec-16-19 07:00AM	Organovo and Tarveda Therapeutics Announce Definitive Merger Agreement (Business Wire) +24.12%
Nov-21-19 07:19AM	Will Organovo Continue to Surge Higher? (Zacks) -9.33%
Nov-18-19 09:18AM	Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys (Zacks)
Nov-15-19 07:06AM	What Bargain Hunting? Tap 5 Stocks With Rising P/E (Zacks) +13.75%
Nov-07-19 10:30AM	Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Oct-03-19 07:34AM	The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo (Benzinga) +8.25%
Oct-02-19 07:31PM	Organovo Acknowledges Receipt of Proposal (GlobeNewswire) +5.94%
Sep-11-19 01:29PM	How Does Organovo Holdings, Inc. (NASDAQ:ONVO) Affect Your Portfolio Volatility? (Simply Wall St.)
Sep-06-19 09:36AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Organovo Holdings, Inc.- ONVO (GlobeNewswire)
Aug-08-19 08:50PM	Organovo (ONVO) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -7.93%
Aug-07-19 09:00AM	Organovo to Explore Strategic Alternatives and Implement Restructuring Plan (GlobeNewswire) -26.48%
Aug-01-19 10:32AM	Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-18-19 08:05AM	Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results (GlobeNewswire)
Jul-09-19 02:59PM	What Kind Of Shareholders Own Organovo Holdings, Inc. (NASDAQ:ONVO)? (Simply Wall St.) +5.15%
Jul-08-19 08:05AM	Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting (GlobeNewswire)
Jun-26-19 06:57AM	Investors are still embracing 3-D printing despite some big IPO misfires (MarketWatch)
Jun-25-19 08:37AM	Penny Stocks to Buy Using Technical Analysis for June 2019 (Investopedia) -6.14%
Jun-13-19 08:05AM	Organovo to Present at Raymond James Life Sciences and MedTech Conference (GlobeNewswire)
Jun-10-19 12:36PM	Options Traders Expect Huge Moves in Organovo (ONVO) Stock (Zacks) +25.06%
Jun-05-19 01:16AM	Edited Transcript of ONVO earnings conference call or presentation 22-May-19 9:00pm GMT (Thomson Reuters StreetEvents) -12.21%
May-30-19 08:05AM	Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease (GlobeNewswire) +103.36%
May-24-19 07:44AM	The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice (Benzinga) -14.62%
May-22-19 04:05PM	Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results (GlobeNewswire) -39.46%
May-17-19 08:05AM	Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results (GlobeNewswire)
Apr-26-19 01:01PM	The Organovo Holdings (NASDAQ:ONVO) Share Price Is Down 83% So Some Shareholders Are Rather Upset (Simply Wall St.)
Apr-17-19 08:05AM	Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean (GlobeNewswire)
Mar-14-19 08:05AM	Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference (GlobeNewswire)
Feb-20-19 08:05AM	Organovo Appoints New Board Member (GlobeNewswire)
Feb-13-19 03:29AM	Edited Transcript of ONVO earnings conference call or presentation 7-Feb-19 10:00pm GMT (Thomson Reuters StreetEvents) +5.88%

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ONVO

Organovo Holdings Inc

Upgrade your FINVIZ experience